Related papers: On the role of surrogates in the efficient estimation of treatment effects with limited outcome data

On the role of surrogates in the efficient estimation of treatment effects with limited outcome data

URL: http://arxiv.org/abs/2003.12408v5
Date: Thu, 10 Oct 2024 13:55:55 GMT
Title: On the role of surrogates in the efficient estimation of treatment effects with limited outcome data
Authors: Nathan Kallus, Xiaojie Mao,
Abstract summary: We study how incorporating data on units for which only surrogate outcomes not of primary interest are observed can increase the precision of ATE estimation. We develop robust ATE estimation and inference methods that realize these efficiency gains.
Score: 43.17788100119767
License:
Abstract: In many experimental and observational studies, the outcome of interest is often difficult or expensive to observe, reducing effective sample sizes for estimating average treatment effects (ATEs) even when identifiable. We study how incorporating data on units for which only surrogate outcomes not of primary interest are observed can increase the precision of ATE estimation. We refrain from imposing stringent surrogacy conditions, which permit surrogates as perfect replacements for the target outcome. Instead, we supplement the available, albeit limited, observations of the target outcome with abundant observations of surrogate outcomes, without any assumptions beyond unconfounded treatment assignment and missingness and corresponding overlap conditions. To quantify the potential gains, we derive the difference in efficiency bounds on ATE estimation with and without surrogates, both when an overwhelming or comparable number of units have missing outcomes. We develop robust ATE estimation and inference methods that realize these efficiency gains. We empirically demonstrate the gains by studying long-term-earning effects of job training.

Related papers

Continuous Treatment Effects with Surrogate Outcomes [12.548638259932915]
We study the role of surrogates in estimating continuous treatment effects. We propose a doubly robust method to efficiently incorporate surrogates in the analysis.
arXiv Detail & Related papers (2024-01-31T20:50:18Z)
B-Learner: Quasi-Oracle Bounds on Heterogeneous Causal Effects Under Hidden Confounding [51.74479522965712]
We propose a meta-learner called the B-Learner, which can efficiently learn sharp bounds on the CATE function under limits on hidden confounding. We prove its estimates are valid, sharp, efficient, and have a quasi-oracle property with respect to the constituent estimators under more general conditions than existing methods.
arXiv Detail & Related papers (2023-04-20T18:07:19Z)
Treatment Effect Risk: Bounds and Inference [58.442274475425144]
Since the average treatment effect measures the change in social welfare, even if positive, there is a risk of negative effect on, say, some 10% of the population. In this paper we consider how to nonetheless assess this important risk measure, formalized as the conditional value at risk (CVaR) of the ITE distribution. Some bounds can also be interpreted as summarizing a complex CATE function into a single metric and are of interest independently of being a bound.
arXiv Detail & Related papers (2022-01-15T17:21:26Z)
SurvITE: Learning Heterogeneous Treatment Effects from Time-to-Event Data [83.50281440043241]
We study the problem of inferring heterogeneous treatment effects from time-to-event data. We propose a novel deep learning method for treatment-specific hazard estimation based on balancing representations.
arXiv Detail & Related papers (2021-10-26T20:13:17Z)
Doing Great at Estimating CATE? On the Neglected Assumptions in Benchmark Comparisons of Treatment Effect Estimators [91.3755431537592]
We show that even in arguably the simplest setting, estimation under ignorability assumptions can be misleading. We consider two popular machine learning benchmark datasets for evaluation of heterogeneous treatment effect estimators. We highlight that the inherent characteristics of the benchmark datasets favor some algorithms over others.
arXiv Detail & Related papers (2021-07-28T13:21:27Z)
Confounding Feature Acquisition for Causal Effect Estimation [6.174721516017138]
We frame this challenge as a problem of feature acquisition of confounding features for causal inference. Our goal is to prioritize acquiring values for a fixed and known subset of missing confounders in samples that lead to efficient average treatment effect estimation.
arXiv Detail & Related papers (2020-11-17T16:28:43Z)
Enabling Counterfactual Survival Analysis with Balanced Representations [64.17342727357618]
Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes.
arXiv Detail & Related papers (2020-06-14T01:15:00Z)
Counterfactual Propagation for Semi-Supervised Individual Treatment Effect Estimation [21.285425135761795]
Individual treatment effect (ITE) represents the expected improvement in the outcome of taking a particular action to a particular target. In this study, we consider a semi-supervised ITE estimation problem that exploits more easily-available unlabeled instances. We propose counterfactual propagation, which is the first semi-supervised ITE estimation method.
arXiv Detail & Related papers (2020-05-11T13:32:38Z)
Causal Inference With Selectively Deconfounded Data [22.624714904663424]
We consider the benefit of incorporating a large confounded observational dataset (confounder unobserved) alongside a small deconfounded observational dataset (confounder revealed) when estimating the Average Treatment Effect (ATE) Our theoretical results suggest that the inclusion of confounded data can significantly reduce the quantity of deconfounded data required to estimate the ATE to within a desired accuracy level.
arXiv Detail & Related papers (2020-02-25T18:46:19Z)

This list is automatically generated from the titles and abstracts of the papers in this site.